Member Info for Richob

I think we have been led on a merry dance today for four reasons:
a) No RNS
b) Trading because of a)
c) "Wall Street"
d) Boots
Whilst I can understand b) because of a), the other two seem ludicrous.

Unless I am misunderstanding "Wall Street", it is a Sydney based brokerage firm that wants people to buy and sell shares through it. Their own blurb says that they don't provide "qualitive information", which I have taken to mean information of any quality. I agree that the blurb is correct.

The Boots test does not have FDA approval.

Level two, for those interested had an Uncrossing Trade at 165p and the following:

163 5000
163 5000
162 5000
162 5000
160 5000
160 5000
160 5000
158 5000
155 50000
150 100000
145 70000

The bottom three are people hoping this will go down to that level and seem to have been there a while.

166 5000
169 5000
170 5000
170 5000
170 5000
170 5000
172 5000
172 5000
174 1828
195 38811
200 50000
205 60000
210 70000
260 3000
290 154

There seems to be a gap between 172 and 195 which a nice RNS could bridge quite easily (in my opinion).

In the absence of an RNS, no doubt we will end up seeing the selling and buying of the same shares, much as we appear to have done today and yet another merry dance.

In addition to the 10k batch RNS that we are looking for, we could also see an Integumen update, a Daewoong update, or a BAMS update. What would be most welcome, for numerous reasons, would be an update on any one of the nine cancer treatments.

Whatever stance you are taking, mine hasn't changed. Buy and hold.

Cave Exigo

... the 10k batch that Sir Al has told us is the next step, level two appears to have reread the Q and As and recognised that blue should be the colour.

I am happy to let the green boxes argue with level two.

Cave Exigo

This test does not have FDA approval and has been given an Emergency Use Only approval.

The real and approved test is coming from a small UK based life sciences company.

Cave Exigo

Thanks, Trek.

That explains the slight sp difference.

Interesting that it is traded. Thought this might be a pre requisite of a fuller US listing.

All the best.

Cave Exigo

Apologies if this has been mentioned before but if you Google AVCTF then it brings up a price of $2.38, about £1.82, on the OTC (Over The Counter) market in the US. It would appear this market is run by brokers on shares not yet in the formal US markets.

Not sure if this means that the phrase "The Yanks are coming" might turn out to be true one day but would appreciate any further insight that anyone might have.

All the best.

Cave Exigo

The other week I had to sell 4% of my holding to put a deposit on a hoover for the wife as her birthday was coming up. I didn't notice any impact on the share price but that was probably because there was no red dot announcing it. I do feel better for getting this off my chest though.

On a more serious note, I see that Daewoong have a covid 19 drug cure in human trials. It is a drug that they have developed to help with cytokinic responses to the vaccine and I recall that we recently increased our affiliation with them through Affyxell. Not clear if affimers are being used to target the drug from what I can see but they obviously like the technology as per the extended joint venture.

Obviously too many positive avenues here for my hoover deposit to have an effect.

Also, there doesn't seem much between here and 190p from what I can see and that is without news.

Cave Exigo

The sp drops 10% because the CEO is buying a house.

Let's think about it.

1) The CEO and his wife would like a new and better house.

2) He has had to sell less than 4% of his holding to add to what he is already putting in to buy the house. He has 96% of his shares left plus those he will receive against milestones.

3) Crucially, Directors cannot sell ahead of bad news, or buy ahead of good news.

4) Those that understand this are buying, just as they were before the RNS.

5) What exactly has changed with regard to news flow? Nothing that I can see.

Just my opinion.

Cave Exigo.

Absolutely amateur hour. The guy is buying a house, presumably better than the one he has and in an area where nice houses don't come up very often.

Can't believe the reaction of some so called holders but time to buy.

Cave Exigo

Excellent post benbenben and thank you for the charting confirmation of the (general) upward trend.

Cave Exigo

Not convinced it needs to be us. The fact that it is saliva is probably more important and we know who will be producing the gold standard one of those I think.

Cave Exigo

We appear to have two types of "investor". The first are those that hold and buy because they are aware of the imminent news flow and what Q4 means and the second are those that are chasing an RNS for a quick return.
MMs collect shares by taking the price down and/or putting the price up, usually the former. They don't sell shares they have collected for less than they bought them, so the key question has to be why do they want them? As the first type of investor, I believe I know the answer to that question but everybody should perhaps ask themselves the question.
I wouldn't be surprised if we go blue today as we are clearly nearer to the news flow expected, which is primarily on covid but certainly not limited to it.

All the best.

Unless it is a sell order at a lower price than they paid then I think stop gain is a fair phrase. What would you call it if not?

Thanks.

Cave Exigo

Hiya, Phantom,

I know that they are orders to sell. My assumption is that in order to do that someone would need to have the shares in the first place.

Are you saying that someone can place an order to sell without having shares to sell?

Cave Exigo

Firstly, the sp is shown as 182p as this was the final uncrossing trade.

Secondly, just shows what testing statements from Bojo can do.

On the what will MMs pay, the range is 184 down to 179 and we have people saying they would like to buy at 160, 155, 150 and 145. I did but am not believing that I will be doing so again.

On the what will they cost me to buy side, we have a range from 187 to 194 and what look like stop gains at 190 (49000), 191 (25000), 194 (5000), 195 (40000), 200 (50000), 210 (70000) and 260 (3000). Obviously some people may change their stop gain position unless an RNS takes them out.

Phantom may be able to add and/or comment further on this from the DMA side.

All in all, not a bad day !

Hold and buy for me.

Cave Exigo

There is a link to this from the Cambridge network news site.

I don't understand the graphs etcetera, though I believe others on here would. What I did very nearly understand was the following (one of three) conclusion:

Novel SARS - Cov2 spike glycoprotein assay was developed using recombinant S1 glycoprotein affinity capture on BAMS magnetic beads uniquely functionalized with a HIGH SPECIFICITY AFFIMER.

The last part caught my attention. Apologies if this has been mentioned before.

Cave Exigo

Sounds about right CO.

Some sells on level two (mainly first thing) and now some chunky buys.

Cave Exigo

Excellent posts afamaman

PS

I've always fancied a Saville Row suit.

Cave Exigo

Some good posts today (thanks) despite the second day of MMs grabbing shares. Doesn't look like they have taken that many and you don't need to wonder why they want them if you know all the background to the company.

Another attack in the morning or will Friday fomo kick in?

Even better, a lovely little RNS perhaps?

Cave Exigo

I genuinely believed this would be the case when posting earlier.

Apologies for being wrong, which I believe is down to:

Impatient sellers

MMs utilising the fear factor

Versus

MMs knowing they will need shares

MMs ceasing on impatient sellers

Other tests clearly failing

The careful stated approach described by Sir Al has proven to be correct

Manufacturers are signed up

If anyone sees this differently, I would be pleased to hear it.

Cave Exigo

Seems strange, at least to me.

Whilst I still think we could finish blue (no I am not mad), the MMs are keen to collect shares from somewhat impatient holders.

The competition is reducing daily and Sir Al has told us how crucial this stage is for success.

As the sold shares pass cheaply to the well researched and we'll read, we do a curve a better base despite the contrary efforts of the MMs.

All the best.

Cave Exigo.